John Spoors, MSc, is the head of Commercial Medicines Policy Analysis, NHS England
John works in the Medicines Analysis Team (MAT) at NHS England and supports a number of commercial policy areas including horizon scanning, Advanced Therapy Medicinal Products (ATMPs) and managed access. John and his team work closely with commercial colleagues, the DHSC and NICE to ensure activity is based on a robust and analytical policy platform.
John has degrees in politics, economics and natural sciences from the University of Manchester and Open University respectively. He has an MSc in Public Health from the London School of Hygiene and Tropical Medicine, and is currently undertaking a part-time PhD there, looking at patient preferences in relation to ATMPs.
Prior to joining NHS England in 2018, John directed and delivered global pricing and market access projects in a wide range of therapy areas across the drug development cycle.
Member of the EXCITE International Payers' Advisory Committee